[New] FDA is shifting its default standard for drug approvals, announcing that one adequate and well-controlled clinical trial will generally be sufficient for approvals.
pharmexec
[New] More drug resistant superbugs are spreading, and projections suggest that by 2050 they could be responsible for more than 10 million deaths worldwide each year.
ScienceDaily
[New] Eli Lilly announced it's working with Nvidia to build an AI factory for drug discovery and co-innovation lab in San Francisco that will create new scientific and technical roles.
BioPharma Dive
[New] Eli Lilly plans to open a $3.5 billion weight-loss drug manufacturing plant in Pennsylvania's Lehigh Valley, creating 850 permanent jobs.
Ermer and Suter PLLC
[New] The US Food and Drug Administration will now review Moderna's new, messenger RNA-based flu vaccine after all, reversing course on a decision that rocked the biopharmaceutical industry last week.
American Chemical Society
[New] The drug industry will have to wait and see whether the FDA's approach to promising experimental therapies changes.
WPLG
[New] The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products.
WPLG
[New] Google's DeepMind has leveraged AI to predict protein folding, a breakthrough with profound implications for drug design and material engineering.
Nature
[New] Generative AI has the potential to accelerate early-stage drug breakthroughs, reducing timelines by 25% or more.
Fortune
[New] After the announced transition period, the Saskatchewan Drug Plan will no longer cover the reference biologic medication.
Government of Saskatchewan
[New] Patients who are currently using an affected reference biologic medication will need to transition to a biosimilar version by the end of the announced transition period to maintain Saskatchewan Drug Plan coverage of their treatment.
Government of Saskatchewan
[New] Pharmaceutical companies such as Amgen, Eli Lilly, and Pfizer are expected to grow their leadership by investing in new injectables, patient support programs, and education for specialists.
Precedence Research
[New] Starting in 2028, prescription drug plan sponsors must allow any pharmacy meeting standard contract terms and conditions to participate in their networks.
Buchanan Ingersoll & Rooney PC
[New] Pharmaceutical supply chain integrity is critical for patient safety, with counterfeit medications representing a significant global health threat.
Mobile App Development Company
[New] By Drug Type, the hormone replacement therapy (HRT) segment is expected to expand at the fastest CAGR of 8.1% between 2024 and 2034 By Distribution Channel, the retail pharmacy segment captured more than 39% of revenue share in 2023.
Precedence Research
[New] The 2026 regulatory environment in the EU is tightening, with new pharmaceutical legislation aimed at reducing the period of data exclusivity for new drugs, which could impact long-term profitability. / UK
The Chronicle-Journal
[New] Reductions in NIH funding and regulatory delays could result in dozens fewer new drug approvals and disrupt tens of thousands of patients enrolled in clinical trials.
AJMC
Last updated: 24 February 2026
Hi,
Would you like a quick online demo of our service from an experienced member of our team?
